| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.087 | 0.1 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.082 | 0.1 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.1 |